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Abstract 
Despite the importance of somatosensation during motor development, a comprehensive 
characterization of the typical development of somatosensory function in children does not 
exist. This is largely due to a lack of objective measures with appropriate resolution. 
Mapping trajectories of typical development of proprioceptive and haptic function is 
necessary in order to identify sensory deficits in pediatric patient populations with known 
or suspected proprioceptive and/or haptic deficits. One such population is children treated 
with chemotherapy for pediatric cancers. Chemotherapeutic agents used to treat cancer 
generate unwanted side effects including peripheral nerve damage called chemotherapy-
induced peripheral neuropathy (CIPN). To date, the magnitude and timeline of 
somatosensory impairments due to CIPN are not well understood. We have updated a 
methodology of measuring proprioceptive acuity and developed a novel measure of haptic 
acuity and sensitivity that are appropriate for use in both adult and pediatric populations. 
The aims of this study were to apply these two assessment tools to characterize 1) 
proprioceptive and 2) haptic function during typical development, 3) measure 
somatosensory-related impairment in individuals treated with chemotherapy for pediatric 
cancer, and 4) identify relationships between chemotherapy-related somatosensory 
impairment and therapeutic markers such as cumulative dosage of chemotherapeutic 
agents. Methods: To map the development of proprioceptive acuity, 308 typically 
developing (TD) children (ages 5-17 years) and 26 adults (ages 18-25 years) performed 
a forearm position matching task with a bimanual manipulandum. Haptic acuity 
(discrimination) or sensitivity (detection) was measured using curvature perception 
assessments in 59 and 56 children respectively (ages 9-12 years). Healthy adults 
completed both haptic assessments (n = 27, ages 19-25 years). These proprioceptive and 
haptic assessments were utilized to characterize somatosensory impairment in 15 
individuals treated with chemotherapy for pediatric cancers (ages 6-25 years). Results: 
First, proprioceptive development is characterized by a reduction in random limb position 
matching error, not a change in systematic limb position error. Second, haptic acuity and 
sensitivity does not change significantly after the age of 9 years. Third, these 
somatosensory assessments were able to characterize proprioceptive and haptic 
impairment in individuals treated with chemotherapy for pediatric cancer. 7 of 15 cancer 
survivors exhibited proprioceptive precision measures above the 75th percentile and 11 of 
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15 exhibited at least one haptic function measure above the 75th percentile of their age-
matched cohort. Fourth, a multiple linear regression model of cumulative dosage of 
chemotherapeutic agent types predicted 80% of the variability in the haptic discrimination 
thresholds (adjusted R2 = 0.80). Conclusion: This work generated a complete 
characterization of the development of proprioceptive acuity in TD children and 
established haptic function is adult-like by the age of 9 years. This study also 
demonstrated proof-of-concept for identifying somatosensory deficits in individuals treated 
with chemotherapy for pediatric cancers. These objective, clinically appropriate, 
somatosensory assessments and the necessary normative development data established 
here can identify or monitor somatosensory deficits in pediatric populations with known or 
suspected deficits.   
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Introduction 
Proprioception is the awareness of limb and body position and motion as well as a sense 
of heaviness (Goldscheider 1898). Proprioceptive signals originate from 
mechanoreceptors embedded in the joints, tendons, muscles, and skin. Intact 
proprioception is essential for the control of muscle tone and voluntary movement. Haptic 
perception refers to “active touch,” that is the moving of hands, fingers or other body 
surfaces to extract object features such as texture, hardness orientation, or shape (Gibson 
1966). Haptic perception relies on proprioceptive signals as well as signals from the skin 
mechanoreceptors that encode touch-related information such as pressure and texture. 
Many tasks of daily living that involve object handling and manipulation rely on haptic 
information (Klatzky, Lederman and Metzger 1985, Kalisch et al. 2012). Similarly, 
proprioception is essential for the control of muscle tone and voluntary movement. Both 
of these sensory modalities are essential for the control and development of balance and 
fine motor function in children and adolescents. 
Despite the importance of proprioceptive and haptic information for motor control, the 
typical development of proprioceptive and haptic function is not well understood. These 
somatosensory modalities are difficult to measure objectively and with appropriate 
resolution in children. The lack of universally accepted measures of proprioceptive and 
haptic function have created a knowledge gap in the understanding of somatosensory 
development in typically developing (TD) children.  
Despite the shortcoming of current sensory measures, numerous pediatric conditions such 
as cerebral palsy, autism, or developmental coordination disorder are associated with 
proprioceptive or haptic deficits that adversely affect motor behavior and motor 
development (Goble, Hurvitz and Brown 2009, Wang et al. 2009, Zwicker, Harris and 
Klassen 2013, Kaufman and Schilling 2007, Coleman, Piek and Livesey 2001, Li et al. 
2015). Consequently, haptic and proprioceptive dysfunction in pediatric populations 
disrupts somatosensory development, which has long-term consequences potentially 
contenting into adulthood. Thus, a comprehensive characterization of the development of 
proprioception and haptics in children is necessary. These normative data are essential 
for the identification and monitoring of pediatric populations with somatosensory deficits. 
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One specific application is for chemotherapy-induced peripheral neuropathy (CIPN). CIPN 
is a common and morbid health consequence of therapy affecting patients treated with 
chemotherapy for cancer. This is especially of concern with pediatric cancers where 
sensory injury is occurring during somatosensory development. Current methods of 
measuring CIPN have the same shortcomings of current somatosensory measures. Given 
the lack of sensitive, universally accepted measures the time course and extent of 
recovery from somatosensory impairment in CIPN is poorly understood. Additionally, 
current measures have been unable to consistently identify the magnitude of sensory 
impairment associated with specific agents or to understand the efficacy of strategies to 
prevent CIPN (Moore and Groninger 2013). Moreover, the impact of somatosensory 
dysfunction due to prolonged chemotherapeutic treatment on sensorimotor development 
is unknown. At present, few objective data exist on how somatosensation in children is 
altered during and after chemotherapy treatment (Jain et al. 2014, Lavoie Smith et al. 
2013, Moore and Groninger 2013).  
We have developed two objective, quick-to-execute, high-resolution measures for 
proprioceptive and haptic function. The work described here applied these measures to 
map the development of somatosensation in TD children and to establish the magnitudes 
of chemotherapy-related somatosensory impairment in patients with pediatric cancer. 
Aims 
Two separate studies were conducted. The first study characterized developmental norms 
of proprioceptive and haptic ability to be used as reference for assessing somatosensory 
deficits in pediatric cancer populations. The second study obtained objective measures of 
the magnitude of proprioceptive and haptic impairment associated with exposure to 
chemotherapeutic agents during treatment for pediatric cancer. The studies had the 
following specific aims:  
Aim 1: Characterize the development of proprioceptive acuity in typically 
developing children. A bimanual manipulandum will be employed with a contralateral 
forearm position matching task to measure both the random and systematic errors in 
forearm position matching across the developmental span in 10-to-20 children at each 
year of age between 5 and 17 years and 20 adults ages 18 to 25 years. Presentation and 
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analysis of developmental trends in forearm position matching errors for children and 
adults will verify this aim. 
Aim 2: Characterize the development of haptic acuity and sensitivity in typically 
developing children. A haptic block system will be employed with two curvature 
perception tasks to measure both haptic acuity and haptic sensitivity across the 
developmental span in 10-to-20 children at each year of age between 5 and 17 years and 
20 adults ages 18 to 25 years. Presentation and analysis of developmental trends in haptic 
acuity and sensitivity for children and adults will verify this aim. 
Aim 3: Establish the magnitudes of proprioceptive and haptic sensory impairment 
during treatment in individuals treated with chemotherapy for pediatric cancers. To 
assess proprioceptive deficits, the bimanual manipulandum and the same forearm position 
matching task from Aim 1 will be used. Values for the random and systematic position 
matching errors from the individuals treated with chemotherapy will be compared with the 
developmental norms generated in Aim 1. Similarly, the haptic acuity and sensitivity 
assessments from Aim 2 will be applied in this patient population. The haptic acuity and 
sensitivity thresholds from these individuals will be compared with thresholds from age-
matched controls. Individuals in the chemotherapy treatment group with proprioceptive 
bias or precision measures outside the 75th percentile of the normative data will indicate 
proprioceptive impairment. Individuals in this group with haptic thresholds greater than the 
75th percentile of the age-matched normative cohort will indicate haptic impairment. The 
presentation of proprioceptive matching task error values and haptic thresholds for this 
group will verify this aim. 
Aim 4: Identify relationships between observable somatosensory dysfunction and 
demographic, clinical, and therapeutic markers. Correlation analyses will be 
performed to identify variables (age, diagnosis, time since diagnosis, and cumulative 
dosage of chemotherapeutic agents) that predict observable proprioceptive and haptic 
impairment. Proprioceptive or haptic assessment outcomes significantly correlated with 
any of these variables will verify this aim. 
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Background 
Somatosensation includes touch, proprioception, temperature, and pain sensation. This 
work focuses on the somatosensory components touch and proprioception. In this work, 
somatosensory measures are specifically referencing these two aspects of 
somatosensation. Proprioception, or kinesthesia, is also a collective term and includes 
position sense, passive motion sense, active motion sense, and gravito-inertial sense or 
a sense of heaviness (Goldscheider 1898). The proprioceptive acuity assessment 
discussed and applied in this work specifically measures limb position sense acuity. 
Similarly, haptic perception refers to “active touch,” that is the moving of hands, fingers or 
other body surfaces to extract object features such as texture, hardness orientation, or 
shape (Gibson 1966, Gibson 1986). The haptic assessments in this work only measure 
the ability to perceive shape via active touch, specifically curvature perception.  
Mechanoreceptors for proprioception and haptics 
Proprioceptive signals originate from mechanoreceptors embedded in the joints, tendons, 
muscles, and skin. Intact proprioception is essential for the control of muscle tone and 
voluntary movement. Muscle spindles embedded in muscle tissue are considered the 
primary sensory organs for limb and body position and motion sense (Gardner and 
Johnson 2013). The firing rate of muscle spindles is related to the length of the muscle (or 
stretch) as well as the lengthening velocity (Pearson and Gordon 2013). The structure of 
the muscle spindle are mature in children by the age of 3 years (Österlund et al. 2011). 
This suggests that any changes in proprioceptive acuity occurring after the age of three 
are associated with the somatosensory pathways at the spinal level or higher.  
The haptic task in this study involves proprioception as well as tactile or touch sensation 
using the glabrous skin on the pad of the index finger. The four main mechanoreceptors 
involved (and the associated fiber type) are the Merkel cells (SA1), Meissner corpuscles 
(RA1), Ruffini endings (SA2) and Pacinian corpuscles (RA2). Each receptor type has a 
specific receptor density and receptive fields, but all occur in the pad of the finger. While 
all of these receptors are likely active during the haptic discrimination and detection tasks 
applied in this study, the perception of curvature likely relies most on Merkel cells, which 
encode for edges and form, the Meissner corpuscles, which encode lateral skin 
movements, and the Ruffini endings, which encode pressure and skin stretch. All four 
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receptor types are innervated by large (Aα) and medium nerve fibers (Aβ) (Gardner and 
Johnson 2013). 
The afferent sensory information from both the proprioceptive and tactile 
mechanoreceptors travels through the dorsal column, medial lemniscal, and 
thalamocortical pathways to the primary somatosensory cortex (Gardner and Johnson 
2013). Other cortical areas involved in proprioceptive and haptic perception include the 
cerebellum and basal ganglia (Lisberger and Thach 2013, DeLong and Wichmann 2009, 
Wichmann and DeLong 2013, Aman et al. 2014).  
Current knowledge of the typical development of limb position sense 
acuity 
Limb position sense acuity improves between 5 and 7 years of age and slowly continues 
to approach adult levels throughout adolescence (Bairstow and Laszlo 1981, Elliott, 
Connolly and Doyle 1988, Goble et al. 2005, Laszlo and Bairstow 1980, Visser and Geuze 
2000). A comprehensive description of the typical development of limb position sense is 
not available because of the shortcomings of the applied methods used in previous 
research, small sample sizes, and/or limited age ranges that were tested. Noted 
shortcomings aside, previous literature demonstrate a major difference between 5 and 8 
years of age so the inclusion of this age group is important for a complete developmental 
trajectory of proprioceptive acuity (Bairstow and Laszlo 1981, Laszlo and Bairstow 1980, 
Elliott et al. 1988). Recently, Goble et al. have used contralateral, ipsilateral-remembered, 
and contralateral-remembered forearm matching tasks to measure limb position acuity in 
children. These tasks involve a bimanual manipulandum that restrict forearm movement 
to rotation in the horizontal plane, elbow flexion and extension (Goble et al. 2005). The 
results of this study are consistent with those discussed above demonstrating changes in 
limb position sense throughout adolescence (Laszlo and Bairstow 1980, Visser and Geuze 
2000). However, compared to earlier studies, which often measured from 100 or more 
individuals, this study included only 18 participants in two age groups (8 - 10 and 16 - 18 
years of age).  
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Shortcomings of previous measures of limb position acuity in children 
There is no established assessment for proprioceptive acuity. This is in part because 
proprioceptive function is difficult to measure objectively and accurately. Clinical rating 
scales are useful but often they require significant time, equipment, and specialized 
personnel (Haryani et al. 2017, Moore and Groninger 2013, Mohrmann, Armer and 
Hayashi 2017). Meanwhile, they may not have sufficient resolution to detect differences 
in proprioceptive acuity.  
Objectively measuring proprioceptive acuity is further complicated by requirements 
associated with pediatric populations. Assessments must be simple to understand and 
incorporate simple movements so motor ability does not affect the proprioceptive 
measure. The Kinesthetic Sensitivity Test (KST) task used in several studies involved 
moving both arms simultaneously up two ramp inclines and determining which ramp is 
steeper (Bairstow and Laszlo 1981, Laszlo and Bairstow 1980). This movement requires 
rotation at both the shoulder and elbow so this is not a simple movement. Since the arms 
moves up the ramps against gravity the amount of force, or effort, to move the arms up 
the different ramp angles while a valid component of proprioception, this is a combination 
of force applied as well as limb position perception. Elliott et al. noted that for the youngest 
age group tested, seven children could not differentiate between the largest possible ramp 
differences of 20°. Twenty five percent of  5 and 6 year old children were correct half of 
the time or less (which is the same as random guessing) (Bairstow and Laszlo 1981). This 
demonstrates that the ramp incline differentiation task itself was potentially too difficult to 
be accurately perceived by children. In addition, the task requires memory of the spatial 
position of the arms as responses are given after the movement up and back down the 
ramp. This response delay could further deteriorate the measure, if attention is not 
maintained. Psychophysical test methods, while the gold-standard method for estimating 
perceptual thresholds, require a large number of trials. Laszlo and Bairstow noted that the 
loss of attention in children is of concern for measures with more than 30 trials without 
breaks (Bairstow and Laszlo 1986).   
Livesey et al. developed a Kinesthetic Acuity Test (KAT) method with passive center-out 
movements in the horizontal plane (Livesey and Intili 1996). While the movement of this 
test is perpendicular to gravitation forces, the outcome measure is the correct number of 
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responses out of the total number of trials (Livesey and Intili 1996, Livesey 2002). Although 
this percent correct score type is informative, it does not provide information about the 
components of acuity, meaning it does not differentiate random and systematic errors. 
The same scoring system was also used with the KST ramp method. This type of score is 
not a weighted score and does not indicate the difficulty level of the stimulus for each 
correct or incorrect response. Compared to a raw error measure (magnitude), this type of 
measure confounds systematic errors in kinesthetic acuity with response variability. For 
example, individual responses may have larger magnitudes of absolute errors compared 
with an adult, while the mean raw error can still be similar. The difference is a greater 
variability in the child’s responses compared to an adult. A correct/incorrect response 
recording method that is not weighted cannot obtain this information.  
Thus, the methods and outcome measures utilized in the study of kinesthetic acuity have 
provided a vague trajectory of the development of limb position sense. Moreover, these 
assessments have not been able to consistently differentiate KAT assessment to 
differentiate children with Developmental Coordination Disorder (DCD) from typically 
developing children (Hoare and Larkin 1991, Lord and Hulme 1987, Piek and Coleman-
Carman 1995). However, the coarse scale of the test and a non-weighted total of correct 
responses, likely contributed to the fact that significant differences between these groups 
were not always found (Hoare and Larkin 1991, Lord and Hulme 1987). 
Equipment and procedural design for object assessment of limb 
position acuity  
Ideal assessments are objective, require minimal equipment, and are easily administered 
as specialized staff are generally not available in clinical settings (Haryani et al. 2017, 
Mohrmann et al. 2017). In addition, to be accepted for clinical use an assessment must 
be completed quickly to reduce the demands on staff as well as address the fact that 
assessments require high levels of attention and younger children can only focus on the 
sensory assessment for a short period of time. Finally, equipment must appropriately scale 
to the anthropometrics of all participants ranging from small children to large adults. The 
proprioceptive assessment must be appropriate for the modality of proprioception one 
desires to measure, position or motion sense. Position sense is easier to assess with a 
non-motorized system as precise control of movement velocity is not required. Next, one 
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needs to select if acuity or sensitivity will be measured. Sensitivity is defined as the ability 
to detect a stimulus where acuity is the ability to discriminate or compare between two 
similar, detectable stimuli.  
Based on the work of Goble et al. and Elangovan et al., we designed a bimanual 
manipulandum to address these requirements (Goble et al. 2005, Goble 2010, Elangovan, 
Aman and Konczak 2014a, Elangovan, Herrmann and Konczak 2014b). The 
manipulandum was used here to quickly, objectively, and precisely measure position 
sense acuity via a contralateral arm position matching task. The contralateral task 
removes the cognitive requirement of remembering a previously presented position that 
is a component of ipsilateral matching tasks (Elangovan et al. 2014b, Goble et al. 2005, 
Goble 2010). The method utilized by Goble et al., involves active motion to match the 
position of a passively moved reference limb. Employing active matching movements is a 
trade-off that allows for numerical error measures in limb position matching without the 
large number of trials required for psychophysical methods. The potential confound 
between motor ability and limb position sense acuity can be reduced by allowing the 
participants as much time as desired to match the limb position. Goble et al. also address 
that the type of joint matching task utilizes various neural structures in addition to the 
primary somatosensory area (Goble 2010). For example, a contralateral matching task 
requires transfer of sensory information between hemispheres and ipsilateral tasks utilize 
memory to match position so impairments or the development of the structures required 
for these processes may confound the limb position sense acuity measure (Goble et al. 
2005, Goble 2010). 
The limb position matching tasks described by Goble et al. are an improved measure of 
limb position sense acuity as one can separate the components of acuity, bias and 
precision, while keeping the length of testing to a minimum. Bias is an indication of 
systematic error, or how close a response is to the target (I.S.O 1994). Precision is defined 
as the random error, or the spread in repeated responses (I.S.O 1994). Both of these 
characteristics of acuity can be measured with the limb position matching equipment and 
assessment utilized here (see Figure 1 for a visual depiction of bias and precision).  
Using a joint position-matching task for assessing proprioceptive acuity is a hybrid 
assessment that involves both a passive sensory stimulus and an active response to 
9 
 
match the reference limb position. This hybridization allows for quick and objective 
calculation of limb position acuity as well as a more natural assessment of proprioceptive 
acuity than pure passive measures. However, the active matching generates an efference 
copy of the motor command of the movement that is available to the central nervous 
system to predict the movement outcome (Wolpert, Pearson and Ghez 2013). This means 
that the active joint-position-matching task is not a pure sensory measure and responses 
may be influenced by: 1) the internal predicted sensory information for the matching 
movement, 2) the processing of afferent sensory information of the moving limb, and 3) 
the integration of these two pieces of information to generate a percept of the forearm 
positions (Konczak et al. 2012, Blakemore, Frith and Wolpert 2001, Von Holst 1954). 
Similarly, developmental differences in motor ability could affect the responses in the limb 
position matching assessment. To minimize this potential confound, the movement task 
was simplified (single joint, one degree-of-freedom, flexion/extension movement of the 
elbow, forearm movement in the horizontal plane perpendicular to gravity). Participants 
were given as much time as desired to achieve the desired forearm position. The limb 
position measure was made at rest so it emphasized the limb position, not the movement 
to achieve that position. These factors minimize any potential influence of movement 
Figure 1: Hypothetical probability distribution of the limb position matching errors with the components of 
acuity labeled. Bias represents systematic error in limb position matching and precision represents random 
error in limb position matching responses. Modified from Holst-Wolf et al. 2016 Figure 1a. 
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ability (movement acceleration or speed) on the desired perceptual measure. The limb 
position-matching task via bimanual manipulandum is not perfect, but generates 
informative measures of acuity in a relatively short time span which is ideal for measuring 
the development of proprioception in children. For these reasons, it was used here as an 
objective measure of proprioceptive acuity. 
We assessed proprioceptive acuity at three different positions as Goble et al. have 
demonstrated that higher amplitudes of limb displacement is associated with higher limb 
position matching error (Goble et al. 2005). To account for possible differences in limb 
position acuity across the workspace, we included a near, intermediate, and extended 
position (40º, 60 º, and 90 º target positions) within the typical forearm/elbow joint range 
of motion.  
Typical development of haptic function 
Haptics requires active touch and the involvement of multiple sensory modalities so the 
development of haptic acuity and sensitivity depends on several components including the 
development of individual sensory modalities, motor behavior to execute exploratory 
procedures, and integration of sensory information from multiple modalities. Evidence in 
animal models and pre-term human infants suggest that tactile stimulation is functional 
before birth and it plays an important role in perceptual and cognitive development 
(Lickliter 2000, Weiss 2005, Parsons et al. 2010). Haptic perception, which requires active 
touch, is also functional in infancy. Rose  et al. have demonstrated that at 12 months 
infants discriminate between different shapes by noting that infants spent more time 
handling novel shapes than ones that were previously handled in a familiarization 
condition  (Rose, Gottfried and Bridger 1981). Similarly, Rochat demonstrated that three 
month old infants can discriminate between hard and soft objects manipulated in the hand 
further demonstrating the functionality of early haptic perception (Rochat 1987). An 
important component of this finding was how discrimination was measured, by how the 
object was handled by the infants. They either held the assessment object in a clutch 
grasp or in quick squeeze-release pattern. This demonstrates that the motor ability 
necessary to assess certain object properties such as hardness or softness is also 
functional in infancy. As haptics requires active touch, a comment on motor development 
is appropriate for discussing haptic related object manipulation. Kalagher et al. found that 
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haptic exploratory procedures in children ages 3 to 5 years were adult-like, meaning 
typical motor development for grasping and individual finger movements are functional by 
this age and allow for the same hand movement patterns adults use to assess object 
properties through active touch (Kalagher and Jones 2011, Lederman and Klatzky 1987).  
Studies investigating the development of tactile sensitivity, rather than simple functionality, 
such as moving two-point discrimination have shown that this type of tactile perception 
appears to be adult-like by the age of 4 years old (Hermann Richard, Novak Christine and 
Mackinnon Susan 1996). However, haptic size discrimination is still maturing in 8-10 year 
old children (Gori et al. 2008). In a study of curvature discrimination using a robotic 
manipulandum, Gori et al. also demonstrated that haptic acuity is improving throughout 
childhood and is not adult-like by the age of 14 years (Gori et al. 2012). While these are 
important general findings none of these studies have mapped haptic acuity across the 
entire developmental span. Gori et al. have come the closest measuring haptic acuity from 
ages 6 to 14 years but their study only included 33 children in this age range which is not 
sufficient to estimate normative percentiles for haptic maturation across development.  
Equipment and procedure for objective assessment of haptic function  
Haptic assessments are multimodal assessments meaning they require active touch or 
exploratory procedure and perception of at least two sensory modalities, typically touch 
and proprioception. A commonly employed haptic paradigm is object recognition via 
haptic exploration with the hand. This type of assessment provides information about the 
functionality of haptic perception but does not easily provide for measure of acuity and 
sensitivity. Here acuity is defined as the ability to discriminate between two stimuli and 
sensitivity is the ability to detect a stimulus. The system used by Gori et al. (2012), which 
created virtual curvatures via a robotic manipulandum, could measure both aspects of 
haptic perception. However, this equipment is expensive, requires specialized 
personnel, and is not portable. Additionally, the psychophysical method employed 
required 40 trials, a significant amount of time. Thus, it was not well suited for use with 
children or in a clinic setting. We designed a modified version of this assessment by 
manufacturing a set of plastic blocks with set curvatures. This set of haptic curvature 
blocks could be used with the same 2-option-forced-choice paradigm to measure either 
haptic acuity or sensitivity. We also identified a different psychophysical threshold 
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adaptive algorithm typically employed in visual perception research that required fewer 
trials to estimate a perceptual threshold (Prins 2013). Thus, we created a portable haptic 
curvature assessment that does not required specialized personnel and can be 
completed in 20 or 25 trials. Individuals were allowed to self-select the number of lateral 
finger movements (>4 times), the movement kinematics (velocity, acceleration), and the 
magnitude of the block surface explorations (did the movements remain in the middle of 
the block or move all the way to the lateral surface edges). The intent of minimizing 
limitations was to simplify the haptic assessment so individuals could focus on the 
perceptual task without having to continually attend to the rules. This allowed for a more 
ecological test measure as well as one that was appropriate for younger children. We did 
not measure kinematics of haptic exploration and purposely placed minimal limitations 
on haptic exploration.  Individuals were not provided a strategy for haptic exploration. 
However, the application of systematic strategy in the two haptic tasks (discrimination 
and detection) may result in different weighting of sensory afferents. For curvature 
detection, a strategy of horizontal hand movement may be employed with emphasis on 
the perception of the pressure on the finger pad. For discrimination, a strategy of 
attempting to maintain constant pressure on the pad of the finger while focusing on the 
perception of the hand/forearm movement trajectory may be employed. Essentially, the 
strategy being maintaining constant input from one type of sensory information while 
focusing on the perception of changes in the other sensory modality. There is nothing 
wrong with adapting different strategies for the assessments but this was not controlled 
for and needs to be acknowledged when interpreting the results of the two haptic 
assessments. 
Chemotherapy induced peripheral neuropathy (CIPN) 
In the U.S. approximately 15,000 children and young adults are diagnosed with cancer 
every year (Childhood Cancer Research Fund, 2017). While the 5-year-survival rate has 
reached 80%, there are many potential short- and long-term health consequences related 
to prescribed therapies (Childhood Cancer Research Fund, 2017). CIPN is a common and 
morbid health consequence affecting patients with pediatric cancers. Exposure to multiple 
classes of chemotherapeutic agents can cause peripheral nerve damage (Tracy, Tracy 
and Dyck 2008, Seretny et al. 2014). However, there is no gold standard for measuring 
peripheral neuropathy, making it difficult to identify the incidence rates of CIPN in children. 
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Estimates for neuropathy incidence range from 3% up to 78% in pediatric populations, 
noting each study used different measures and definitions of CIPN (Moore and Groninger 
2013, Lavoie Smith et al. 2015). It is understood that the negative effects of chemotherapy 
correlate with the type of agent, number and cumulative dosage of agents as well as the 
time since administration of the agents (Moore and Groninger 2013). Higher incidents 
rates are typically found in populations treated with a combination of agents that include 
vinca alkaloids like vincristine (Moore and Groninger 2013, Lavoie Smith et al. 2015). 
However, the lack of clinically appropriate, high-resolution measures of CIPN make it 
difficult to perform consistent and objective assessments over time to characterize the 
timeline of the effects (Moore and Groninger 2013, Mohrmann et al. 2017, Haryani et al. 
2017).  
Current assessments of CIPN in children 
Nerve conduction velocity has been found to be abnormal during chemotherapy in up to 
87% of individuals treated for pediatric cancers (Kava et al. 2017). However, nerve 
conduction velocity measures in the clinic typically requires involvement of a neurologist. 
This measure also requires specialized equipment as well as being an uncomfortable 
procedure so this measure is not standard practice during chemotherapy treatment. The 
Pediatric-Modified Total Neuropathy Score (ped-mTNS) (Gilchrist and Tanner 2013) has 
been used to get an overall measure of CIPN. While the validity and repeatability of this 
rating scale has been documented, the measures rely in part on subjective patient 
responses (Gilchrist and Tanner 2013, Gilchrist, Marais and Tanner 2014). Moreover, the 
non-interview components of the ped-mTNS, such as monofilament testing, vibration 
testing, light touch sensation, manual muscle testing, and deep tendon reflex measures 
require an array of tools and personnel with significant training to reliably and repeatedly 
administer these test components (Gilchrist and Tanner 2013). Lavoie Smith et al. have 
created another rating scale very similar to that of the ped-mTNS called the Total 
Neuropathy Score – Pediatric Vincristine (TNS©-PV) (Lavoie Smith et al. 2013, M. et al. 
2015). This assessment is similar to the ped-m TNS with the inclusion of subjective patient 
assessment of symptoms, temperature sensitivity, vibration sensitivity, muscle strength, 
tendon reflexes, autonomic symptoms, and laryngeal symptoms (Lavoie Smith et al. 
2013). While useful, these rating systems require a significant amount of time to complete 
making repeated measures over time a concern as they can become burdensome for both 
14 
 
hospital staff and the patients (Haryani et al. 2017). While the components of the ped-
mTNS and TNS©-PV target a broad range of sensory fibers, they neglect large-fiber based 
proprioception, which is a key component of functional motor behavior, leaving the 
magnitude of proprioceptive impairment due to CIPN unknown. To our knowledge, there 
are no objective measures of proprioceptive and haptic function currently in general 
clinical use in pediatric oncology.  
While the effects of chemotherapy may be temporary, there are indications that 
somatosensory impairment persists past treatment. A cross-sectional assessment of 
nerve conduction velocity and reduced Total Neuropathy Score in pediatric survivors 
(within 3 years of treatment) of acute lymphoblastic leukemia found 33% were identified 
with neuropathy by either measure (Jain et al. 2014, Haryani et al. 2017). Another study 
demonstrated that a proportion of adult survivors of pediatric extracranial cancers treated 
with vinca alkaloids or platinum-based chemotherapies have been shown to have 
neuromuscular (17.5%) and sensory (20%) dysfunction when measuring with dorsiflexion 
strength and the modified Total Neuropathy Score, respectively (Ness et al. 2012, Ness 
et al. 2013). Furthermore, somatosensory dysfunction is associated with poor mobility and 
endurance in these adults (Ness et al. 2013). Surveys aimed at establishing functional 
physical performance deficits in long-term survivors of pediatric cancers have found that 
survivors are more likely than their non-treated siblings to report limitations that affect self-
care, performance of routine activities, and the ability to attend work or school (Ness et al. 
2005).  
In the final component of this study, we applied the proprioceptive and haptic assessments 
in a group of individuals treated with chemotherapy for pediatric cancer. These 
assessments provided an objective evaluation of chemotherapy-related proprioceptive 
and haptic effects. The haptic acuity and sensitivity assessments were included to 
evaluate distal peripheral nervous system pathways and mechanoreceptors. Evidence 
suggests CIPN symptoms often present with the stocking-and-glove neuropathy pattern 
(Moore and Groninger 2013). The haptic assessments were recently shown to have 
appropriate resolution to differentiate between typically developing children and children 
with DCD that have mild to moderate somatosensory impairment (Tseng et al. manuscript 
in preparation 2018).  
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Methods 
Study 1 participants: TD children and healthy adults 
Adult participants were recruited at the University of Minnesota and at the Minnesota State 
Fair. All younger participants were recruited from a local primary school or at the 
Minnesota State Fair. Appropriate consent, and when appropriate assent, was obtained 
before data collection. The study was approved by the University of Minnesota Internal 
Review Board. All participants reported no central or peripheral nervous system disease 
or disorder, no implanted medical devices in the arms, and no upper limb injury that would 
impair the ability to sense limb position or the sense of touch. Inclusion criteria also 
required that participants were able to attend to the assigned assessments for 5-20 
minutes (with breaks as needed). All subjects completed a modified Edinburgh 
handedness inventory to determine the dominant limb for testing.        
Table 1: TD and healthy adult participants that completed the proprioceptive acuity 
assessment.  
Group Age Range (years) N Male/Female 
Children 5-17 308 127/181 
Adults 18-25 26 12/14 
 
Table 2: TD and healthy participants that completed at least one of the haptic acuity 
assessments.  
Assessment Group 
Age Range 
(years) N Male/Female 
Discrimination Children 9-12 59 29/30 
Detection Children 9-12 56 24/32 
Discrimination and Detection Adults 19-25 27 12/15 
 
Study 2 participants: individuals treated with chemotherapy for 
pediatric cancers 
All patient participants were recruited at the Journey Clinic which is the University of 
Minnesota Masonic Children’s Hospital Pediatric Oncology Clinic. Appropriate consent, 
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and when appropriate assent, was obtained before data collection. The study was 
approved by the University of Minnesota Internal Review Board and Cancer Protocol 
Review Committee. All patient participants reported no central or peripheral nervous 
system disease or disorder, no implanted medical devices in the arms, and no upper limb 
injury that would impair the ability to sense limb position and the sense of touch. Patients 
were also excluded if they had a cranial cancer diagnosis. Inclusion criteria required that 
participants were able to attend to the assigned assessments for 5-20 minutes (with 
breaks as needed). The final inclusion criteria was that the individual had been given some 
form of chemotherapy for a pediatric cancer such as vinca alkaloids (like vincristine or 
vinblastine). All subjects completed a modified Edinburgh handedness inventory to 
determine the dominant limb for testing. One child completed two of the assessments but 
was removed from the study due to lack of compliance with task instructions, their data is 
not included here.     
For table of chemotherapeutic agent types and chemotherapeutic agents given to each 
individual see Appendix I. 
Table 3: Characteristics of patient participants that completed at least one of the 
proprioceptive and/or haptic acuity assessments.  
Group Age (years) M/F Diagnosis 
Time since 
diagnosis (months) 
Children 6 M Lymphoma 17 
 9 M Langerhan’s cell histiocytosis 17 
 10 F Ewing’s sarcoma 18 
 13 F Leukemia 22 
 16 F Ewing’s sarcoma 23 
 17 F Nodular sclerosis, Hodgkin’s lymphoma  1 
Adults 18 M Ewing’s sarcoma 34 
 18 M Leukemia 38 
 19 F Hodgkin’s lymphoma 4 
 20 F Acute lymphoblastic leukemia 14 
 21 F Hodgkin’s lymphoma 39 
 21 M Leukemia 20 
 24 F Malignant neoplasm 132 
 24 F Lymphoma, pancreatic tumor 39 
 25 F Leukemia 47 
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Apparatus: proprioceptive acuity assessment  
A bimanual manipulandum with one degree of freedom in the horizontal plane was used 
to perform bilateral arm position matching as the proprioceptive acuity assessment. Two 
U.S. Digital H6 optical encoders (2500 quadrature count/revolution spatial resolution: 
0.14º), housed at the rotating point of the manipulandum lever arms, recorded the angular 
position of each arm.   
Procedure: proprioceptive acuity assessment 
Participants placed each forearm onto one of the manipulandum levers. The lever arm 
length and handle placement was adjustable such that the center of rotation of the elbows 
was directly over the encoders while the participant comfortably gripped the handles. The 
distance between the two levers could be adjusted such that the participants’ elbows were 
a comfortable distance apart. An adjustable height chair was used to get the appropriate 
angle between the upper arms and forearm so that the forearms were approximately just 
above waist height (45° to 85° of shoulder abduction) with the participant seated.  Between 
target positions participants rested each arm in front of the torso at a reference (or start) 
position set at 30° from the frontal plane (see Figure 3). During testing the non-dominant 
arm was passively moved in the horizontal plane away from the body at a consistent speed 
of 20°–30°/second to one of three target positions, 40°, 60°, or 90° from the frontal plane 
of the participant. Once the researcher moved the non-dominant arm to a target position, 
the participant was asked to move the dominant arm to match the position of the other 
arm. Target positions were presented in pseudo random order such that each position 
Figure 2: Manipulandum lever length, handle placement, and elbow/shoulder width flexibility of the bi-
manual manipulandum are adjustable to conform to the user’s anthropometrics. Modified from Holst-Wolf 
et al. 2016 Figure 1c and 1d. 
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was repeated 5 times for a total of 15 trials. Three different target positions were included 
as increasing the amplitude of the limb displacement is associated with greater error 
(Goble et al. 2005) and we here sought to account for possible developmental differences 
of position sensing across the forearm workspace. Participants had as much time as 
desired to match the position and when given the verbal ready signal by the participant, 
the researchers recorded the position of each arm at 60Hz for 1.6 seconds (70 samples). 
Once the recording finished for that trial the researcher moved the non-dominant hand 
back to the reference position and gave a verbal cue for the participant to actively move 
the dominant arm back to the reference position. Participants wore vision occluding 
glasses during all trials so their arms were not in view. Participants were instructed to 
match the position of the arms by perceiving their position. One or two practice trials 
preceded data collection to ensure the instructions of the task were understood before 
data collection began. If the researcher or child visibly moved during the 1.6 second 
recording, for example if an arm was brought back to the start position early, the trial was 
repeated or the trial data was truncated at the point the movement towards the reference 
position began and a new average was calculated with the truncated data (mean of fewer 
than 70 samples).This assessment requires approximately 5-10 minutes to complete 
depending on how long the individual takes to find the desired forearm matching position 
and if the participant requests any breaks during the 15 trials. (This procedure was 
previously described in Holst-Wolf et al. 2016.) 
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Measures: proprioceptive acuity assessment  
The physical position of each forearm is defined as the average of the 70 samples 
recorded over 1.6 seconds. The average position of the dominant matching arm was 
subtracted from the average position of the reference arm for each trial (Pdiff).  
𝑃𝑑𝑖𝑓𝑓 = 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛𝑚𝑎𝑡𝑐ℎ 𝑎𝑟𝑚 − 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑎𝑟𝑚 
For each participant, the position error (PE) was then calculated as the mean of Pdiff across 
the five trials for each of the target positions (40°, 60° and 90°).  
𝑃𝐸𝑖 = (∑ 𝑃𝑑𝑖𝑓𝑓,𝑖
𝑛
1
) 𝑛⁄
  
  
Similarly, the corresponding standard deviation (SDPdiff) for each participant was 
calculated as the standard deviation of the five Pdiff across the five trials for each target 
position. PE is an indicator of bias, or systematic error, while SDPdiff denotes the precision 
of forearm position matching for each individual.  
𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝐷𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 (𝑆𝐷𝑃𝑑𝑖𝑓𝑓) = 𝑃𝑑𝑖𝑓𝑓,𝑖        𝑤ℎ𝑒𝑟𝑒 𝑖 𝑖𝑠 40° ,60° ,90°  
where n is the number of trials in each 
condition (n = 5) and i is  40° ,60° ,90° 
Figure 3: A child seated at the bi-manual manipulandum performing bi-lateral, concurrent forearm position 
matching. The starting position (30̊) and the three target positions (40̊, 60,̊ and 90 ̊elbow extension) are 
shown for reference. Modified from Holst-Wolf et al. 2016 Figure 1b. 
20 
 
To create an overall limb position acuity score, the percentiles of PE and SDPdiff for each 
age group and target position were calculated (early childhood: 5-6, middle childhood: 7-
9, late childhood: 10-11, adolescence: 12-17, and adults 18-26 years old) (Payne 2008).  
To generate a single proprioceptive bias and precision score for each individual’s bias and 
precision measures, the average of each individual’s 3 bias percentiles and 3 precision 
percentiles were calculated.  
𝑃𝑟𝑜𝑝𝑟𝑖𝑜𝑐𝑒𝑝𝑡𝑖𝑣𝑒 𝐵𝑖𝑎𝑠 𝑆𝑐𝑜𝑟𝑒 =  (%𝑃𝐸40, %𝑃𝐸60, %𝑃𝐸90)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  
𝑃𝑟𝑜𝑝𝑟𝑖𝑜𝑐𝑒𝑝𝑡𝑖𝑣𝑒 𝑃𝑟𝑒𝑐𝑖𝑠𝑜𝑛 𝑆𝑐𝑜𝑟𝑒 =  (%𝑆𝐷𝑃𝑑𝑖𝑓𝑓40, %𝑆𝐷𝑃60, %𝑆𝐷𝑃90)
̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅ 
The average of all 6 percentiles (bias and acuity) were calculated for each individual to 
give them an overall limb position acuity score (units are percentile).  
𝑃𝑟𝑜𝑝𝑟𝑖𝑜𝑐𝑒𝑝𝑡𝑖𝑣𝑒 𝐴𝑐𝑢𝑖𝑡𝑦 𝑆𝑐𝑜𝑟𝑒 =  (%𝑃𝐸40, %𝑃𝐸60, %𝑃𝐸90, %𝑆𝐷𝑃𝑑𝑖𝑓𝑓40, %𝑆𝐷𝑃60, %𝑆𝐷𝑃90)
̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅ 
For all study participants, each participant’s age at the date of data collection was 
calculated in years and months and converted to a decimal in base 10 (a year was divided 
into 10 equal sections).    
Apparatus: haptic acuity and sensitivity assessments 
This system includes a set of high precision custom-made plastic blocks (tolerance < +/- 
0.1 mm). Blocks have identical width and length (20 mm x 150 mm). Each block has a 
defined curvature, heights vary from flat (30mm center-point-height) to highly curved (50 
mm center-point-height).  
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Procedures: haptic acuity and sensitivity assessments 
For the haptic acuity assessment (discrimination), the participant manually explores two 
curved blocks per trial, one after another. The index finger of the dominant hand probes 
the surface curvature of the presented block up to four times with lateral (back-and-forth) 
finger/forearm movements. After exploring the two blocks, the participant verbally 
indicated which block is more curved. The binary response ‘first’ or ‘second’ is coded by 
correctness, which depends on the random presentation order of the blocks (1 for correct 
and 0 for incorrect). The correctness is entered by the experimenter into custom-built 
software and an adaptive algorithm selects the next stimuli difference based on response 
correctness and past differences in curvature. After 20 trials, the program fits a logistic 
Weibull function to the response data (Prins 2013) and calculates the haptic just-
noticeable-difference (JND) discrimination threshold, an objective measure of haptic 
function. The haptic sensitivity assessment (detection) utilizes the same probing method 
as the acuity assessment but only one block is presented in each trial. The participant is 
then asked to verbally indicate if the block is ‘flat’ or ‘curved.’ The binary response is coded 
by correctness (1 or 0) and entered into the custom software. The adaptive algorithm 
selects the next stimuli based on the correctness of the response and the stimuli 
magnitude. The flat block is presented 5 times throughout the assessment in pseudo-
random order (once in every 5 trials). After 25 trials, the program fits a logistic Weibull 
Figure 4: Left – an individual explores the curved surface of a block in a lateral, side-to-side, motion of the 
index finder of the dominant hand. The haptic curvature block system with center point curvatures from – 
0mm (flat) to 20mm center point height. The base of each block is 150 mm long x 30mm high x 20mm 
wide. The curvature height is added to the base height so the block with the most curvature has a center-
point-height of 30mm + 20mm = 50mm. Modified from Tseng et al. manuscript 2018 Figure 1a and 1b. 
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function to the response data (Prins 2013) and calculates the haptic just-noticeable-
difference (JND) detection threshold. Participants wear opaque glasses to occlude vision 
of their hand and forearm for both the haptic acuity and sensitivity assessments. 
 
Measures: haptic acuity and sensitivity assessments 
The adaptive algorithm used by both the haptic acuity and sensitivity assessments selects 
stimuli based on the correctness of the previous response and the previous stimulus 
magnitude. After 20 trials for the acuity assessment and 25 trials for the sensitivity 
assessment, the program fits a logistic Weibull function to the response data (Prins 2013) 
and calculates the haptic just-noticeable-difference (JND) discrimination or detection 
threshold respectively. 
Study design 
Study 1: The characterization of proprioceptive acuity across development study had a 
cross-sectional design including children ages 5 to 17 years old and adult references ages 
18 to 26 years old. The characterization of haptic acuity and sensitivity (discrimination and 
detection) was a cross-sectional study. Adults completed both the haptic acuity and 
sensitivity assessments and most children completed both assessments with a subset 
completing only one of the two. The presentation order of the haptic assessments was 
pseudo-randomized to minimize any potential effect of fatigue. 
Study 2: The investigation of somatosensory impairment in individuals treated with 
chemotherapy was also a cross-sectional study. Each individual completed the 
proprioceptive acuity assessment and most completed both of the haptic assessments. 
One individual opted out of the haptic acuity assessment and one individual opted out of 
Figure 5: Block presentation of one trial for each the haptic acuity (discrimination) task on the left, and the 
haptic sensitivity (detection) task on the right. Modified from Tseng et al. 2018 Figure 1c.   
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the haptic sensitivity assessment. The presentation of the three somatosensory 
assessments was pseudo-randomized to minimize any potential effect of fatigue.  
Measures: demographic, clinical, and therapeutic markers 
The cumulative dosage of each chemotherapeutic agent prescribed was tabulated for 
each individual treated with chemotherapy for pediatric cancers. Units are typically in 
mg/m2 or mg though some individual agents are in mg/kg or IU/m2. All dosages of 
individual agents were in the same units except for vincristine which is in mg/m2 or mg. 
The latter is used in instances where the limit on the total amount of vinca alkaloids allowed 
to be given to a single individual based on body weight was reached. As there were 28 
different chemotherapeutic agents prescribed the cumulative dosage of agents were 
grouped by agent type (see Table 4). Types are differentiated by the chemical composition 
of the agents and the mechanism of how the agents react on a cellular level 
(Chemocare.com 2018). For example, alkylating agents are a group of several different 
chemicals that are cell-cycle non-specific while plant alkaloids are a group of several 
chemical compounds derived from plants that are cell-cycle specific, meaning their cellular 
level affects are specific to a certain cell division phase (Chemocare.com 2018). Time 
since diagnoses was calculated as the time since the date of test to the time of initial 
cancer diagnoses rounded to the nearest month for each individual.  
For all study participants, each participant’s age at the date of data collection was 
calculated in years. 
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Table 4. The chemotherapeutic agents (units) prescribed to the individuals in this study 
grouped by agent type. For clarity, when 1) only a single agent is used within an agent 
type and 2) for the antineoplastics (miscellaneous agents), the agent name listed on the 
right will be used in this document.  
Agent Type Therapeutic Agents (units)  
Plant alkaloids Vincristine (mg/m2 or mg), Vinblastine (mg/m2), 
Vinorelbine (mg/m2) 
Anti-tumor antibiotics Bleomycin (IU/m2), Anthracycline (mg/m2) 
Alkylating agents Ifosfamide, Procarbazine, Cyclophosphamide,  
Carmustine ( all mg/m2) 
Antimetabolite Nelarabine (mg/m2), Methotrexate (mg), 
Mercaptopurine (mg/m2), Thioguanine (mg/m2), 
Cytarabine (mg/m2), IT ara-c (mg) 
Antineoplastic PEG-asparaginase (IU/m2), Brentuximab (mg/kg), 
Topotecan (mg/m2) 
Topoisomerase inhibitors Etoposide (mg/m2) 
Enzyme Erwinia (IU/m2) 
Signal transduction inhibitor Imatinib (mg) 
Monoclonal antibody Rituximab (mg/m2) 
Cranial radiotherapy Cranial XRT (cGy) 
Glucocorticosteroid Prednisone (mg/m2), Dexamethasone (mg/m2), 
Hydrocortisone (mg) 
Results 
Development of limb position sense: bias and precision in TD children 
and healthy adults 
The individual responses of Pdiff, measuring limb position sense, from all 334 typically 
developing and adult controls were distributed about zero degrees (zero error) across all 
ages for each of the three target positions (see Figure 6). The next step was to 
characterize the components of acuity bias and precision. To characterize systematic 
changes in bias across development, a repeated measures ANOVA on PE was performed 
(chronological age x 3 target positions x 2 gender x 2 handedness). There were no 
significant main effects on PE (p > 0.05) indicating that chronological age, target position, 
handedness, and gender did not affect PE. There was a significant interaction between 
target position and age (p = 0.048), but linear regression of PE by chronological age were 
not significant for the 40º and 60º target positions. The regression of PE by chronological 
age for the 90° target position was significant (p = 0.04). Yet, the adjusted coefficient of 
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determination for this linear model indicated that chronological age only explained 1% of 
the variability in PE90 (R2adjusted = 0.01). 
 
To address development-related change in precision the SDPdiff data were analyzed. The 
SDPdiff data distribution was non-normal so this was corrected with a log (base 10) 
transformation. A repeated measures ANOVA of the log transformed data (chronological 
age x gender x target position x handedness) found no significant main effects or 
interactions of gender and handedness (p < 0.05). A reduced model (chronological age x 
target position) revealed significant main effects of both chronological age and target 
amplitude (p < 0.001 for each) but no significant interaction. These indicate that precision 
is influenced by both age and target amplitude. Non-linear quantile regression procedures 
were utilized to estimate the percentiles for SDPdiff across age for each of the three target 
positions. For each amplitude, SDPdiff decreased as age increased (see Figure 8).  
Figure 6: Forearm limb position matching (Pdiff) data for all typically developing children (n = 308) and 
adults (n = 26) that completed the proprioceptive acuity assessment for each of the three target positions. 
Modified from Holst-Wolf et al. 2016 Figure 2. 
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Figure 8: Quantile regression of the absolute value of PE based on the normative cohort. This is the 
normative data to be used as a comparison with the individuals treated with chemotherapy for pediatric 
cancer. 
40̊ 60̊ 90̊ 
Figure 7: SDPdiff from each individual for all three target positions are shown by the circles. The 5th, 25th, 
50th, 75th, and 95th percentiles were determined by quantile regression of the SDPdiff data by age and are 
depicted by the lines and shaded areas. Note that precision is age and target position dependent. Modified 
from Holst-Wolf et al. 2016 Figure 3. 
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To examine if the age-related trend in SDPdiff is associated with any age-related trend in 
PE, a linear regression for SDPdiff with PE as the predictor for each of the three target 
positions was conducted. All three regressions were significant (p < 0.05). However, at 
most only 12% of the age-related change in SDPdiff was explained by PE (R2adjusted: 0.12 
for 40º, 0.10 for 60º, and 0.05 for 90º) 
Characterizing CIPN-related proprioceptive impairment 
To assess impairment in proprioceptive acuity in the patient group, additional linear 
regression analysis on the control data on the absolute value of the systematic error (PE) 
by age was performed to generate the percentiles for systematic limb position matching 
error during development for each of the three target positions. Five individuals (38%) 
treated with chemotherapy are above the 75th percentile for their age group in at least one 
target position and one person was above the 95th percentile for the 40º target position 
(see Figure 7 for normative data, Figure 9 for data from individuals treated with 
chemotherapy). 
Similarly, when comparing limb position precision, 46% of individuals (7 of 15) are above 
the 75th percentile compared to the age-matched controls for at least one target position 
and 6 individuals (38%) are above the 95th percentile for at least one position (see 
Figure10). Five of the adults were above the 75th percentile for two of the target positions. 
There were no children consistently above the 75th percentile. 
To further summarize proprioceptive acuity in this patient group, the average bias, 
precision, and overall limb position acuity scores (averages of percentiles of the normative 
cohort for each of the three target positions) were calculated by age group. None of the 
limb position acuity scores were above the 75th percentile. One bias score and two 
precision scores were above the 75th percentile, none were above the 95th. 
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Figure 10: The 5th, 25th, 50th, 75th, and 95th percentiles for the normative cohort of limb position matching 
precision (SDPdiff) by target position (40º, 60 º, 90 º) across age are depicted by the lines and shaded 
areas. Precision (SDPdiff) of each individual treated with chemotherapy for pediatric cancers are the circles. 
Note 7 individuals treated with chemotherapy have at least one measure above the 95 th percentile of the 
normative cohort.  
Figure 9: Linear regression analysis for absolute value of PE for the 5th, 25th, 50th, 75th, and 95th percentiles 
of the normative cohort for the three target positions (40º, 60 º, 90 º). Note there are 6 individuals treated 
with chemotherapy (circles) with at least one abs(PE) measure above the 75th percentile for their age-
matched normative cohort. 
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Haptic acuity and sensitivity in TD children and healthy adults 
Haptic acuity and sensitivity data from TD children ages 9 to 12 and adults ages 18 to 25 
were collected. It was found that in the age range of 9-12 years, haptic acuity thresholds 
(discrimination) were not significantly different from those of adults while the haptic 
sensitivity thresholds (detection) in adults was lower on average, the difference did not 
reach statistical significance (p > 0.05) (Tseng et al. manuscript in preparation 2018). For 
the individuals in the normative cohort that completed both the discrimination and 
detection assessments (n = 74), there was no apparent correlation between the two 
thresholds (linear fit adjusted R2 = 0.01).  
 
Characterizing CIPN-related haptic impairment 
To assess haptic impairment in individuals treated with chemotherapy for pediatric 
cancers the JND thresholds for haptic discrimination (acuity) and detection (sensitivity) m 
compared with the thresholds of typically developing children and adults in the control 
group. Most of the individuals treated with chemotherapy, 64% of individuals (9 of 14), had 
Figure 11: Boxplots of the haptic discrimination (acuity) and haptic detection (sensitivity) thresholds are 
shown for the typically developing children (ages 9-12 years) and adult controls. For each boxplot, the 
center line is the median, the box ranges from the 25th to the 75th percentile and whiskers represent +/- 
2.7*SD giving 99.3%. Data were collected in collaboration with Tseng et al.2018. Note there is no apparent 
developmental trend in this age range. 
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haptic discrimination (acuity) thresholds above the 75th percentile of the normative data. 
With respect to haptic detection (sensitivity), 50% of individuals (7 of 14) treated with 
chemotherapy were above the 75th percentile for their group. Two individuals were 
distinctly above the 95% for their age matched cohort. In the 14 patients that completed 
both assessments there was a mild correlation between the discrimination and detection 
thresholds (linear fit adjusted R2 = 0.19). When looking at the values of both thresholds 11 
of the 15 individuals treated with chemotherapy had at least one of the two threshold above 
the 75th percentile for their age matched cohort and 8 individuals were above the 75th 
percentile for both thresholds.  
An assessment of the scatterplots to identify relationships between the proprioceptive and 
haptic assessment values found no strong trends (limb position bias score, limb position 
precision score, limb position acuity score, haptic discrimination JND threshold, and haptic 
detection JND threshold). The discrimination and detection JND thresholds had the 
strongest relationship with an adjusted R2 value of 0.18.  
Figure 12: Boxplots of the normative haptic discrimination and detection data for children (ages 9 to 
12 years) and adults (ages 19 to 25 years). The circles indicate discrimination or detection thresholds 
of individuals treated with chemotherapy for pediatric cancers. Individuals in this group ages 6 to 17 
are plotted with the children group and individuals ages 18 and older are plotted with the adult data.   
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Correlations between CIPN-related somatosensory impairment and 
demographic, clinical, and therapeutic markers 
After verifying the assumptions of each type of statistical analysis, correlation analyses 
were conducted between the 1) limb position bias score, 2) limb position precision score, 
3) the overall limb position acuity score, 4) the haptic discrimination (acuity) JND threshold, 
and 5) the haptic detection (sensitivity) JND threshold and the clinical treatment variables. 
For the quantitative clinical treatment variables of age and time since diagnosis (months), 
none of the Pearson correlation coefficients with the sensory measures listed above were 
> 0.40. This indicates there were no relationships between the sensory measures and age 
or time since cancer diagnosis in this sample. To assess a relationship with the categorical 
treatment variable diagnosis, plots of the mean and 95% confidence interval for each of 
the five sensory outcomes by diagnosis were created. There were no trends of note 
between diagnosis and the limb position bias, precision, or overall acuity scores. Haptic 
discrimination thresholds of individuals diagnosed with leukemia were lower than the other 
diagnosis groups. Each of the single individuals diagnosed with either malignant neoplasm 
or Langerhan’s cell histiocytosis had higher discrimination thresholds than the other 
Child patient 
Adult patient 
Children 75% 
Adult 75% 
Figure 13: Discrimination and detection thresholds for each individual treated with chemotherapy. The 
markers on the axes of the graph are the thresholds for the two patients that completed a single haptic 
assessment. The dark grey box represents the 75th percentiles for the adult normative cohort, the light 
grey box represents the 75th percentiles for the normative cohort for the children. The solid line is the 
linear regression fit, the equation and R2 value for the linear fit are on the graph.   
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diagnosis groups. The individual diagnosed with Langerhan’s cell histiocytosis had a 
higher haptic detection threshold than the other groups.  
Rather than generate individual correlations between each chemotherapeutic agent type 
and the sensory measures (as there are 12 agent types applied in unique combinations 
for each individual) multiple linear regression (MLR) after stepwise variable selection 
(using Akaike Information Criterion or AIC) was performed to clarify relationships between 
the sensory measures and the overall cumulative dosage of agents. The agents that were 
only applied in single individuals were removed (Erwinia, Imatinib, Rituximab, Cranial 
XRT, and Topotecan). One thing to note, the individual given Imatinib had the highest 
percentile for the limb position precision score and was above the 75th percentile for both 
the haptic discrimination thresholds (see Figures 15, 16, and 17). The haptic discrimination 
and detection thresholds for the individual given Erwinia were both above the 75th 
percentile for the normative cohort as well (see Figures 16 and 17).  
Several agent types appeared in multiple models (antimetabolites, plant alkaloids, 
alkylating agents, Etoposide, antineoplastics, and glucocorticosteroids). Based on 
adjusted R2 value, the models for limb position bias score and precision score are not well 
explained by cumulative dosage of agent types (see Figures 14 and 15). The best model 
was the fit of the Haptic Discrimination Thresholds with an adjusted R2 of 0.80 (see Table 
5 for all the MLR model adjusted R2 values). The signs and magnitudes of the coefficients 
for plant alkaloids (which includes Vincristine and Vinblastine) and anti-tumor antibiotics 
in the haptic discrimination threshold MLR model indicates a positive relationship, higher 
the cumulative dosage of these agents was associated with a  higher haptic discrimination 
threshold (see Table 6 for model coefficients).  
 
33 
 
 
Figure 14: Cumulative dosage of 12 different types of chemotherapeutic agents arranged by the magnitude of 
the limb position bias score (%). For this and the following 3 bar graphs, the wide bars are for plant alkaloids 
and anti-tumor antibiotics associated with the lower (bold) scale and all other agents with the narrow bars are 
associated with the upper scale. Units of dosage are agent dependent but are typically mg/m2. Imatinib is 
noted with a * because the dosage of this agent is scaled down by a factor of 100 to better fit the scale of rest 
of the agent dosages in the chart. The agent Topotecan is difficult to see, it was given to the individual with 
the limb position bias score of 49 (%). 
 
Figure 15: Cumulative dosage of chemotherapeutic agents arranged by the magnitude of the limb position 
precision score (%). The agent Topotecan is difficult to see, it was given to the individual with the limb 
position precision score of 53 (%). 
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Figure 16: Cumulative dosage of chemotherapeutic agents arranged by the magnitude of the haptic 
discrimination (acuity) threshold. The agent Topotecan is difficult to see, it was given to the individual with the 
haptic acuity threshold of 4.58mm. Note that higher doses of plant alkaloids and anti-tumor antibiotics are 
associated with higher discrimination thresholds.  
 
Figure 17: Cumulative dosage of chemotherapeutic agents arranged by the haptic detection (sensitivity) 
threshold. Thresholds in grey are those of children, thresholds in black are adults. The agent Topotecan is 
difficult to see, it was given to the individual with the detection threshold of 2.87mm. 
mg/m2 
mg/m2 
mg/m2 
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Table 5. Summary of the MLR analysis after variable selection of chemotherapeutic agent 
types for each of the sensory outcomes. The diagnostic residual plots for each model were 
indicated that a linear fit was appropriate, the residuals were normally distributed, and the 
assumption of equal variance was met. Significance levels for the agent types are:  0 ‘***’, 
0.001 ‘**’, 0.01 ‘*’, 0.05 ‘^’, all else 0.1 ‘ ’. 
Sensory Measure Agent Type Adjusted R2 
Limb Position Bias Score 
(Quantile) 
Alkylating agents^, 
Antineoplastics, Etoposide 
0.22 
Limb Position Precision Score 
(Quantile) 
Alkylating agents, Plant alkaloids, 
Etoposide 
0.12 
Limb Position Acuity Score 
(Quantile) 
Plant alkaloids 0.09 
Haptic Discrimination JND 
Threshold 
Alkylating agents, 
Antineoplastics***, Anti-tumor 
antibiotics**, Plant alkaloids***, 
Glucocorticosteroid^ 
0.80 
Haptic Detection JND Threshold Antimetabolite^, Plant alkaloids*, 
Glucocorticosteroid 
0.41 
 
Table 6. MLR model of Haptic Discrimination Threshold coefficient values and statistics. 
Coefficients Estimate Standard Error t-value Pr(>|t|) 
(Intercept) 1.624e+00 6.192e-01 2.622 0.030552 
Alkylating agents  -1.666e-05 1.081e-05 -1.541 0.161874     
Antineoplastics -1.622e-04 2.749e-05 -5.900 0.000362 
Anti-tumor antibiotics   9.625e-03 2.817e-03 3.417 0.009134 
Plant alkaloids 3.262e-02 6.086e-03 5.360 0.000678 
Glucocorticosteroid     -2.533e-04 1.193e-04 -2.124 0.066451 
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Discussion  
This work applied two somatosensory assessments to characterize the development of 
proprioceptive and haptic function in typically developing children. In addition, the clinical 
usefulness of these assessments were examined by applying the tests to small set of 
individuals treated with chemotherapy for pediatric cancer. The main findings are as 
follows: First, typical proprioceptive development continues throughout childhood. 
Second, typical haptic function was not significantly different from adults in the age range 
assessed here. Third, these assessments identified proprioceptive impairment in 47% and 
haptic impairment in 73% of the individuals treated with chemotherapy. Fourth, haptic 
acuity was correlated to cumulative dosage of chemotherapy. These findings are 
discussed in detail below. 
Typical development of proprioception and haptics  
Characterizing typical development of proprioception (Aim 1) 
To my knowledge, this is the first study that comprehensively and objectively characterizes 
the development of limb position acuity from early childhood to adulthood using in a cross-
sectional design. Limb position matching allowed for the analysis of the two components 
of limb position acuity, precision and bias. Measurement of these components 
demonstrated that the development of proprioceptive acuity is characterized by an 
improvement in precision. Meaning, variability in the sensory responses decreased with 
age. No trend in bias across development indicated that the systematic error (consistently 
overshooting or undershooting the target position) did not significantly change in this age 
range.  
The primary mechanoreceptor of limb position sense is the muscle spindle. Muscle 
spindles are mature in children as early as 3 years of age (Österlund et al. 2011). Spinal 
level circuitry maturation can be inferred from Hoffman reflex (H-reflex) responses, which 
are adult-like by 6 to 7 years of age in children (O'Sullivan, Eyre and Miller 1991, 
Grosset et al. 2007). Similarly, in typically developing children, somatosensory evoked 
potential (SEP) morphology is mature by the age of 3 years while the latency is not 
adult-like until ages 6 to 8 years (Laget et al. 1976, Boor, Goebel and Taylor 1998, Boor 
and Goebel 2000). Pihko et al. found that tactile stimulation induced somatosensory 
evoked fields approach adult-like behavior by the age of 2 years but the morphology and 
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latency continue to mature past 6 years of age (Pihko et al. 2005, Pihko et al. 2009). The 
differences in latencies may indicate maturation of the lemniscal and/or thalamo-cortical 
somatosensory pathways. Our population is as young as 5 years of age so differences in 
maturation of the peripheral mechanoreceptors does not completely explain the changes 
we see. The spinal level and thalamo-cortical pathway maturation may only explain 
improvement in proprioceptive acuity at the youngest portion of our dataset where we 
see the greatest differences in proprioceptive precision. 
Changes in the sensitivity of muscle spindles may in-part account for improvement of 
proprioceptive precision during development. Grosset et al. identified differences in the 
stretch reflex responses during development. They found the stretch reflex amplitude, 
which is regulated by gamma motorneuron activation, is changing throughout childhood 
and does not yet reach adult levels by age 11 years (Grosset et al. 2007). Given the 
spinal-level circuitry are mature at this point in development, information from 
supraspinal locations that descend to gamma motorneurons affecting the sensitivity of 
muscle spindles may in-part account for developmental changes in proprioceptive acuity.  
Several additional cortical changes may influence the development of proprioception. 
Nerve axon and dendrite growth as well as changes in the neurotransmitter system 
occur throughout childhood (Nevalainen, Lauronen and Pihko 2014). There are also 
specific structures involved in the processing of somatosensory information that are 
maturing throughout childhood. Nerve axon growth and cytoskeletal changes in the 
corpus callosum into adulthood are documented (Keshavan et al. 2002, Lebel, Caverhill 
Godkewitsch and Beaulieu 2010). The callosal projections are involved in the inter-
hemispheric transfer of perceptual information, which is required by the limb position 
matching task used here. This task requires conveying the limb position information on 
the reference limb to the opposite hemisphere to correctly position the matching arm 
(Goble et al. 2005, Goble 2010). The development of the corpus callosum during 
childhood may account for the developmental trends found here measured with a limb 
position matching task. Recently, tendon-vibration induced illusory movement with fMRI 
measures investigated the development of proprioceptive cortical networks in 
adolescence (Cignetti et al. 2016, Fontan et al. 2017). In children ages 7 to 11 years of 
age, differences in in the level as well as the areas of activation between pre-
adolescents and adults have been found. Children and adults both demonstrated 
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activation in the primary somatosensory and the posterior parietal areas but only the 
children demonstrated activation in the frontopolar cortex (Fontan et al. 2017). Similarly, 
before adolescence, the proprioceptive network is mostly mature but refinement 
continues documented as a shift from diffuse to focal connectivity principally in fronto-
striatal connections (Cignetti et al. 2016). These finding suggest that the cortical 
structures involved in processing of propriopriocetive information are refined throughout 
adolescence. In summary, the developmental timelines of gamma motorneuron 
activation and somatosensory processing are adult-like in childhood but continue to 
develop throughout adolescence. This timeline is in agreement with the trend in the limb 
position matching acuity data found here. The majority of improvement in limb position 
precision occurs by 10 years of age with minor improvements continuing throughout 
adolescence.  
Characterizing typical development of haptic acuity and sensitivity (Aim 2) 
Children ages 9-12 years had adult-like haptic acuity thresholds. While the range and 
average of sensitivity thresholds of children were both larger than the adults were, the 
groups were not statistically different. This is contrary to previous findings which indicate 
haptic development occurs throughout childhood and adolescence (Gori et al. 2008, Gori 
et al. 2012). The first explanation for this contradiction is the limited age range of children 
assessed here. Both Gori et al. studies included younger children and a larger age range 
(5-10 years and 6-14 years). In these studies, children younger than 10 had the largest 
differences in haptic function compared with adults. With the current age range of children 
9-12 years old, we noted a non-significant trend in the sensitivity thresholds compared 
with the adults and this trend may become statistically significant in a younger population. 
Another potential explanation for the contradiction in findings with previous literature has 
to do with the primary sensory modalities required in the different haptic perception tasks. 
The curvature perception haptic task used here involved lateral movements of the forearm 
and hand with the index finger in contact with the curved surface. This curvature 
perception task likely relies on pressure at the fingertip, finger position, and hand/forearm 
position motion which includes sensory information from skin mechanoreceptors as well 
as muscle spindle and Ruffini endings. One of the haptic tasks used prior was a haptic 
aperture task where children were asked to make judgements about the height of pairs of 
39 
 
blocks after grasping them with the thumb and index finger (Gori et al. 2008). The pertinent 
sensory information for this task is hand position, which is informed by muscle spindle and 
Ruffini ending information. The haptic curvature assessment via robotic manipulandum 
employed by Gori et al. 2012 involved movement of the entire arm (mainly proprioceptive 
information from muscle spindles) as the children were grasping a handle throughout the 
curvature perception task. The acuity and sensitivity of different sensory modalities (touch 
information and proprioceptive information) required by these haptic tasks appear to 
mature at different rates. This may explain the lack of developmental differences found in 
the age range of 9-12 years when measuring with a haptic task which more evenly 
emphasizes tactile and proprioceptive information.  
Evidence on the developmental timeline of tactile senses suggests that tactile senses 
develop early. Similar to proprioception, maturation of the peripheral mechanoreceptors 
involved in touch perception appears to occur early in childhood. In murine models, Merkel 
cell SA1 receptors and the peripheral and central nervous system circuitry have been 
found to morphologically mature at or near birth (Woodbury and Koerber 2007). Less is 
known about the development of Pacinian corpuscles and Ruffini endings as they are 
more difficult to find in mouse and non-human primate skin (Jenkins and Lumpkin 2017). 
Study of somatosensory function in kittens found that there were changes in receptive 
field and force thresholds at 50 days of age but noted these were likely due to changes in 
nerve fiber myelination and the mechanical properties of the dermis rather than maturation 
of mechanoreceptors (Beitel, Gibson and Welker 1977). This evidence indicating that 
peripheral aspects of tactile senses are mature very young. Furthermore, the processing 
of tactile sensory information may mature earlier than proprioceptive processing. Tactile 
sensitivity, measured with moving two-point discrimination measures are adult-like by the 
age of 4 years (Hermann Richard et al. 1996).  
We have demonstrated in this study that proprioceptive precision is maturing throughout 
childhood and adolescence. Haptic tasks that emphasize proprioceptive information like 
the aperture perception and full-arm-movement curvature perception task may 
demonstrate greater developmental changes throughout childhood and adolescence 
because of the emphasis on proprioceptive information. The curvature assessment 
employed here may emphasize tactile information more evenly with proprioception thus 
explaining why we did not find significant developmental changes in these haptic 
40 
 
measures in late childhood. The definition of haptics as using active touch to perceive 
characteristics of objects would support the inclusion of a tactile sense in a haptic 
assessment such as the haptic curvature assessment employed here where the index 
finger is in contact with the curved surface.  
However, as the haptic tasks employed here requires both tactile and proprioceptive 
perception we do suspect there would be some developmental changes during childhood 
with the trend shifted younger. Several of the neurophysiological changes that affect 
proprioceptive development will be applicable to haptic function. Cortical axon and 
dendrite growth in somatosensory processing areas and maturation of SEP morphology 
and latency indicating maturation of thalamo-cortical somatosensory pathways indicate 
one could expect small but measurable changes in haptic acuity or sensitivity with 
development in the range of 5 to 18 years of age with the greatest changes found in the 
youngest children (Nevalainen et al. 2014, Laget et al. 1976, Boor and Goebel 2000, Pihko 
et al. 2005, Pihko et al. 2009). As the development of haptic acuity is reliant on 
proprioception, one would expect to see the greatest differences in young children below 
the age of 9 years. The non-significant trend of TD children with higher sensitivity 
thresholds than the adults indicates this measure may be more sensitive to developmental 
changes in haptic ability. A facet of the tactile sensory processing for this specific haptic 
curvature detection task may occur later in development. 
Finally, the haptic assessment applied here allowed individuals to explore the curvature 
up to 4 times. This differed from the Gori et al. curvature perception method which allowed 
for only 2 curvature explorations, over and back. Exploring the curvature more times may 
differentially aid children who have lower proprioceptive precision compared with adults.  
Objective assessment of proprioceptive and haptic function in 
individuals treated with chemotherapy for pediatric cancer 
This is the first known application of objective measures of proprioceptive and haptic 
function in individuals treated with chemotherapy for pediatric cancer. This demonstrates 
for the first time that these assessments can identify proprioceptive and haptic impairment 
in this population. These measures may also provide appropriate resolution to begin 
understanding relationships between specific chemotherapeutic agents and 
somatosensory ability. The multiple regression model with the cumulative dosage of 
41 
 
chemotherapeutic agents explaining 80% in the variability of the measured haptic 
discrimination JND thresholds is a promising early result. 
Identifying CIPN-related somatosensory impairment (Aim 3)  
Each of the proprioceptive and haptic measures identified signs of somatosensory 
dysfunction in a subset of individuals treated with chemotherapy for pediatric cancers. 
With regard to proprioceptive acuity, the measures of bias in the patient group were not 
outside the normative cohort as only one individual was above the 95th percentile for the 
40º target position and less than half of the measures were above the 75th percentile. With 
precision, 46% of individuals were above the 75th percentile and 6 more were above the 
95th percentile for at least one measure (one target position). This would suggest that 
CIPN-related proprioceptive impairment primarily affects limb position precision and does 
not generate a consistent bias. This is similar to findings in other pediatric patient groups. 
Children with developmental coordination disorder demonstrate more variability in a 
forearm limb position matching task as well, although the reasons for the altered 
proprioceptive precision are different between these two populations (Tseng et al. 2017). 
Since there was no trend in bias for the individuals treated with chemotherapy the bias 
score and the overall limb position scores were not informative in this population. The 
precision score may be the best measure to apply in future work to assess proprioceptive 
deficits in pediatric patient populations as there were two individuals with precision scores 
above the 75th percentile. Alternatively, since there is a noted effect of target position, one 
could simply select one or a subset of the three target limb positions included here to 
assess proprioceptive precision.  
With regard to the haptic assessments, 64% and 50% of individuals had acuity or 
sensitivity thresholds above the 75th percentile of the normative cohort. Two individuals 
were above the 95th percentile on the sensitivity assessment. While most of these values 
are within the normal range, they are in the fourth quartile suggesting a mild sensory 
impairment. The consistency of the measured haptic thresholds in this small population of 
individuals treated with chemotherapy and the noted relationships of the haptic acuity 
thresholds with clinical variables (discussed in the following section) suggest that the 
haptic assessment may be better suited to measure CIPN.  
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Relationships between CIPN and clinical variables (Aim 4) 
There were no significant relationships between the proprioceptive and haptic assessment 
measures. The haptic assessment measure of acuity and sensitivity were correlated, the 
haptic sensitivity threshold predicted 18% of the variability in the acuity threshold. This 
lack of agreement between measures is somewhat expected, as the population in this 
study was heterogeneous with regard to age, diagnosis, and treatment factors. This is 
congruent with current literature on CIPN which notes that individual factors such as age 
and genetics as well as treatment factors like chemotherapeutic agent type, agent 
interactions, cumulative dosage, and duration of treatment likely affect the magnitude and 
type of neuropathy (Moore and Groninger 2013, Han and Smith 2013, Fitzgerald 2017). 
Analysis found no statistically significant relationships between the somatosensory 
measures and individual age in this sample. However, all of the individuals with a 
proprioceptive precision measure above the 95th percentile and the majority of individuals 
with haptic acuity and sensitivity thresholds above the 75th percentile were above 18 years 
of age. This is in agreement with prior assessments of CIPN which have indicated that 
age appears to correlate with the severity of neuropathy (Moore and Groninger 2013, 
Fitzgerald 2017). Interestingly, a number of children had very low sensitivity thresholds, 
1st quartile. These findings suggests there may be a correlation with somatosensory 
deficits and age at exposure to chemotherapy. Using a data primarily from murine models, 
Fitzgerald et al. have proposed a mechanism for age-related neuropathic pain. They have 
collected evidence that in young rats the, “neuroimmune response is skewed in an anti-
inflammatory direction, suppressing the excitation of dorsal horn neurons and preventing 
the onset of neuropathic pain.” This immune response switches and becomes 
inflammatory with increasing age (Fitzgerald and McKelvey 2016). While this finding is 
specific to small fiber neuropathy (pain), there may be a similar effect on the large fiber 
somatosensory nerves affecting somatosensation. However, this is a proposed 
mechanism with little data on the presence of this immune response and timeline for this 
response in humans and no evidence of this immune response effects on large fiber 
neuropathy.     
Similarly, there were no significant statistical relationships in sample between the 
somatosensory measures and the clinical variables of diagnosis and time since diagnosis.  
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Haptic discrimination thresholds were correlated with cumulative dosage of several 
chemotherapeutic agent types. Specifically, higher cumulative dosage of plant alkaloids, 
which include Vincristine, Vinblastine, and Vinorelbine, was associated with a higher 
discrimination JND threshold. These agents are known to induce CIPN, often referred to 
as Vincristine-induced peripheral neuropathy (VIPN) (Jain et al. 2014, Lavoie Smith et al. 
2013, M. et al. 2015, Gilchrist and Tanner 2016). Plant alkaloids are antimicrotubule 
agents that prohibit cells from division and replication, which leads to cell death and 
affect both sensory and motor neurons (Moore and Groninger 2013). The exact 
mechanisms of Vincristine neuropathy are still under investigation, but they include 
mitochondrial dysfunction, loss of intra-epidermal nerve fibers, large diameter sensory 
nerve damage, and nerve axon degeneration without demyelination (Han et al. 2013, S., 
D. and D. 2000). Loss of intra-epidermal nerve fibers was commonly associated with the 
use of several types of chemotherapeutic agents as well as being common to other 
peripheral neuropathies, such as diabetic neuropathy (Han and Smith 2013). This may 
explain why a haptic assessment, which requires tactile perception and proprioception 
from distal mechanoreceptors, had the best correlation to cumulative dosage of 
chemotherapeutic agents.  
Limitations and alternative explanations 
Our proprioceptive acuity assessment is appropriate for children ages 5 years and older, 
but it likely is not appropriate for younger children as their attention span and 
understanding of the limb matching task may be limited. The youngest participants in the 
normative cohort for the haptic assessments were 9 years of age. Sufficient data on 
younger children is not currently available, only one individual in the patient group aged 
6 years completed the haptic assessments. Given the simplicity of the assessment it is 
anticipated that young children can successfully complete the assessments.   While the 
haptic assessments require more time to complete, with breaks this should be 
manageable for children as young as 5 years. Unfortunately, the typical vocabulary and 
attention span of children younger than 5 years limits their ability to understand the 
assessment instructions and the ability to attend to perception during the entire test. This 
is a significant limitation as the need for objective, quantitative, high-resolution sensory 
assessments in pediatric populations younger than the age of 5 remains. For example, 
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the majority of pediatric patients treated with chemotherapy for lymphoblastic leukemia 
are younger than the age of 5 during treatment (Lavoie Smith et al. 2013). 
The ability of the model for cumulative dosage of chemotherapeutic agents to predict the 
effects of individual agents on haptic discrimination JND threshold is limited. The 
prescription of these agent types is not entirely independent, for example, 
glucocorticosteroids are often given with antimetabolites and Etoposide with alkylating 
agents. This means the estimates of the relationship of the discrimination threshold with 
individual coefficients must be interpreted with caution as this does not fit the model 
assumptions. However, the entire model is not voided, the variables included as a whole 
do provide for 80% of the variance in the haptic discrimination JND thresholds.  
The individuals in this study that were receiving chemotherapy were also receiving other 
pharmacological agents in addition to chemotherapy. Their prescriptions were reviewed 
for concurrent usage of benzodiazepines, which are known to affect proprioception, but 
there may be other pharmacological agents that have similar effects when used alone or 
with other agents that are not yet recognized. All of the individuals in the group treated 
with chemotherapy were volunteers from an outpatient clinic. There could be a sampling 
bias with regard to the severity of neuropathy measured with the somatosensory 
measures applied here since all of these individuals felt well enough to volunteer to 
participate in a research study.   
Recommendations 
The development of proprioceptive acuity continues throughout adolescence into 
adulthood. Thus, it is important for somatosensory measures to have appropriate 
normative data across development for comparison with pediatric patient populations. 
Further work to develop assessments and normative data for proprioceptive acuity of the 
wrist and lower extremity (ankle assessment) would likely be an asset for measuring 
peripheral neuropathy since peripheral neuropathy generally affects the longest fibers and 
thus the distal portions of the body first (Moore and Groninger 2013, Han and Smith 2013). 
Additionally, assessments for children younger than five years of age are a logical next 
step. Early identification of sensory impairment is especially relevant in a pediatric 
populations as sensory dysfunction is occurring during somatosensory development, 
which is shown here to be incomplete until late adolescence (Holst-Wolf, Yeh and Konczak 
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2016). This is potentially a critical window as tactile and proprioceptive afferents are 
required for intact motor behavior such as fine motor control and balance. These 
temporary or long-term sensory deficits may impair or delay the achievement of 
developmental motor milestones throughout childhood. If neglected, this could result in 
negative psychological and social consequences making the early detection of individuals 
that may benefit from sensorimotor intervention an important component of long-term 
care.  
Given the somatosensory measures used here are quick, objective, and easy to perform 
in a clinic setting, the proposed proprioceptive and haptic assessments have the potential 
to become useful tools to identify and monitor long-term somatosensory dysfunction. Here, 
the haptic discrimination assessment appears best suited to further determine the 
relationships between chemotherapy and somatosensory ability. Further work to verify the 
efficacy of the haptic assessments and proprioceptive acuity assessment to identify 
relationships between sensory impairment and chemotherapy is recommended. 
These objective assessments of somatosensory dysfunction in patients with pediatric 
cancer have the potential to aid clinicians in making informed decisions about the 
administration of chemotherapeutic agents. If correlations between specific 
chemotherapeutic agents or other treatment variables and sensory dysfunction are found, 
this additional information may be used to alter treatment decisions in an attempt to reduce 
negative sensory consequences. It is anticipated that future studies will determine if 
sensorimotor deficits improve in long-term follow-up of patients or normalize following 
completion of therapy. Studies investigating the efficacy of sensorimotor interventions in 
survivors of pediatric cancers to either aid in a return to pre-treatment sensory ability or to 
help shorten the period of sensory recovery would also be warranted. The objective 
sensory measures proposed here may also be useful for the identification and monitoring 
of other patient populations with known or potential sensory dysfunction such as 
individuals with other forms of pediatric cancers, adult cancers, or other neurological 
disease or disorder that affect peripheral nerves such as diabetes.  
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Conclusion 
The typical development of proprioceptive acuity measured by a limb position matching 
task is best described as an improvement in precision, or the reduction of variability in 
proprioceptive perception. Larger improvements in limb position precision occur before 
the age of 10 years and behavior continues to approach that of adults throughout 
adolescence. Haptic acuity and sensitivity as measured by curvature assessment tasks 
with the index finger do not demonstrate significant developmental changes between the 
age of 9 years and adulthood. Further work to assess a younger population is 
recommended to complete the characterization of haptic development in childhood. Both 
the proprioceptive and haptic assessments successfully identified somatosensory deficits 
in individuals treated with chemotherapy for pediatric cancers. While there were no 
apparent trends between the sensory measures and patient age, diagnosis, or time since 
diagnosis, all individuals in this study have a unique combination of these factors and a 
larger sample may be better suited to find relationships between these variables. The 
haptic acuity assessment measure of JND discrimination threshold did successfully 
identify a relationship between CIPN and cumulative dosage of chemotherapeutic agent 
types. Work to further establish the efficacy of these assessments is recommended as 
there is a significant need in pediatric oncology, and neurology in general, for objective 
sensory measures suitable for use in the clinic with sufficient resolution to characterize the 
magnitude of neuropathy.   
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